Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Bauer Website

Thomas R. Bauer Jr., Ph.D.

Selected Publications

1)  Bauer, Jr. TR, Tuschong LM, Calvo KR, Shive HR, Burkholder TH, Karlsson EK, West RR, Russell DW, Hickstein DD.
Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.
Molecular Therapy. 21: 964-72, 2013.
[Journal]
2)  Donahue RE, Tuschong L, Bauer, Jr. TR, Yau YY, Leitman SF, Hickstein DD.
Leukocyte integrin activation mediates transient neutropenia after G-CSF administration.
Blood. 118: 4209-14, 2011.
[Journal]
3)  Hunter MJ, Zhao H, Tuschong LM, Bauer, Jr. TR, Burkholder TH, Persons DA, Hickstein DD.
Gene Therapy for Canine Leukocyte Adhesion Deficiency with Lentiviral Vectors Using the Murine Stem Cell Virus and Human Phosphoglycerate Kinase Promoters.
Human Gene Therapy. 22: 689-96, 2011.
[Journal]
4)  Bauer, Jr. TR, Olson EM, Huo Y, Tuschong LM, Allen JM, Li Y, Burkholder TH, Russell DW.
Treatment of canine leukocyte adhesion deficiency by foamy virus vectors expressing CD18 from a PGK promoter.
Gene therapy. 18: 553-9, 2011.
[Journal]
5)  Hunter MJ, Tuschong LM, Fowler CJ, Bauer, Jr. TR, Burkholder TH, Hickstein DD.
Gene therapy of canine leukocyte adhesion deficiency using lentiviral vectors with human CD11b and CD18 promoters driving canine CD18 expression.
Molecular Therapy. 19: 113-21, 2011.
[Journal]
6)  Ohmine K, Li Y, Bauer TR, Hickstein DD, Russell DW.
Tracking of specific integrant clones in dogs treated with foamy virus vectors.
Human Gene Therapy. 22: 217-24, 2011.
[Journal]
7)  Nelson EJ, Tuschong LM, Hunter MJ, Bauer, Jr. TR, Burkholder TH, Hickstein DD.
Lentiviral vectors incorporating a human elongation factor 1alpha promoter for the treatment of canine leukocyte adhesion deficiency.
Gene Therapy. 17: 672-7, 2010.
[Journal]
8)  Bauer TR, Adler RL, Hickstein DD.
Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems.
ILAR J. 50: 168-86, 2009.
[Journal]
9)  Peranteau WH, Heaton TE, Gu Y, Volk SW, Bauer TR, Alcorn K, Tuschong LM, Johnson MP, Hickstein DD, Flake AW.
Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model.
Biol. Blood Marrow Transplant. 15: 293-305, 2009.
[Journal]
10)  Hai M, Adler RL, Bauer, Jr. TR, Tuschong LM, Gu Y, Wu X, Hickstein DD.
Potential genotoxicity from integration sites in CLAD dogs treated successfully with gammaretroviral vector-mediated gene therapy.
Gene Therapy. 15: 1067-71, 2008.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 6/17/2014.